ADAM10 and cancer: Among them, ADAM10 cleaves MICA, MICB, and ULBP-2 in different types of cancer cells and its increased expression correlates with cancer progression in MM [184], malignant pleural mesothelioma [185], oral squamous cell carcinoma [186], and gastric cancer [187].